Prospective Hyperthermia Database in Cancer Patients (HT Register)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-11-01

Study Completion Date

2028-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance

After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked.

Furthermore there is the possibility in the course of this study to an optional take part in translational accompanying research with the aim of prognostic factors for response to hyperthermia treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat

NCT01290159

Heat Stroke Healthy

COMPLETED

Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC

NCT05426928

HIPEC

RECRUITING

Effectiveness of Heat Donation Through the Head or Torso on Mild Hypothermic Rewarming

NCT01603511

Rewarming by Shivering Heat Production Only Rewarming by External Heat to the Torso Rewarming by External Heat to the Head

COMPLETED NA

Preoperative Hyperthermia in Major Abdominal Surgery Patients

NCT00876954

Colon Cancer

COMPLETED PHASE1/PHASE2

Continuous Temperature Measurement by Thermal Imaging Camera

NCT06256978

Critically Ill

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 1000 patients with various diseases with the indication for hyperthermia in addition to standard oncological therapy (radiation therapy, chemotherapy, radiochemotherapy) will be included in this registry protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperthermia Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hyperthermie Register

Hyperthermia simultaneous with Radiotherapy alone, Hyperthermia simultaneous with Chemotherapy alone, Hyperthermia simultaneous with Radiochemotherapy alone

Hyperthermie Register

Intervention Type OTHER

* die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C),
* die Dauer der Anwendung und
* die simultane Therapie mit Chemo- und/oder Strahlentherapie

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyperthermie Register

* die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C),
* die Dauer der Anwendung und
* die simultane Therapie mit Chemo- und/oder Strahlentherapie

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Contrazeption with female patients at the capable of bearing children age
* Written agreement is present (DvH, ICH-GCP)
* Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion for the interventional study represents.
* With children must the treatment with one of the GPOH agreed Pattern take place